FindTrial
Sign In

A Survey of the efficacy and safety of a antihypertensive drugs to the patients of Chronic Kidney Disease (CKD) with hypertension

A Survey of the efficacy and safety of a antihypertensive drugs to the patients of Chronic Kidney Disease (CKD) with hypertension - A Survey of the efficacy and safety of a antihypertensive drugs to the patients of Chronic Kidney Disease (CKD) with hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000024861
Enrollment
30000
Registered
2016-11-16
Start date
2016-11-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease (CKD) with hypertension

Interventions

None listed

Sponsors

RAD-AR Council Japan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The case by which the following condition is here more than 1. (1) eGFR is less than 60 ml/min/1.73m2 at the beginning of administration (2) Urine protein is more than positive+ at the beginning of administration (3) Patient who has kidney disease for complication. 2) Patient not on dialysis.. 3) Patient who treated with a antihypertensive drugs for more than 1 day.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Change of Blood pressure—

Secondary

MeasureTime frame
Blood pressure lowering effect, Examination of renal function level, Incidence of Event (Vascular brain disease, Cardiovascular disease, Kidney disease), Safety—

Countries

Japan

Contacts

Public ContactTaketoshi Onda

RAD-AR (Risk/Benefit Assessment of Drugs-Analysis & Response) Council Japan Database committee

onda@rad-ar.or.jp03(3663)8891

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026